135 related articles for article (PubMed ID: 34713838)
1. Cause-specific mortality among patients with different molecular subtypes of T1-2N0M0 breast cancer: A population-based study.
Wang D; Yi L; Zhang L; Wang Z
Medicine (Baltimore); 2021 Oct; 100(43):e27605. PubMed ID: 34713838
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
Li X; Zhang X; Liu J; Shen Y
BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
[TBL] [Abstract][Full Text] [Related]
3. All-Cause and Cardiovascular Disease Mortality Among Breast Cancer Survivors in CLUE II, a Long-Standing Community-Based Cohort.
Ramin C; Schaeffer ML; Zheng Z; Connor AE; Hoffman-Bolton J; Lau B; Visvanathan K
J Natl Cancer Inst; 2021 Feb; 113(2):137-145. PubMed ID: 32634223
[TBL] [Abstract][Full Text] [Related]
4. Race differences in cardiovascular disease and breast cancer mortality among US women diagnosed with invasive breast cancer.
Troeschel AN; Liu Y; Collin LJ; Bradshaw PT; Ward KC; Gogineni K; McCullough LE
Int J Epidemiol; 2019 Dec; 48(6):1897-1905. PubMed ID: 31155644
[TBL] [Abstract][Full Text] [Related]
5. Pre- and Post-diagnosis Diabetes as a Risk Factor for All-Cause and Cancer-Specific Mortality in Breast, Prostate, and Colorectal Cancer Survivors: a Prospective Cohort Study.
Tao H; O'Neil A; Choi Y; Wang W; Wang J; Wang Y; Jia Y; Chen X
Front Endocrinol (Lausanne); 2020; 11():60. PubMed ID: 32132977
[No Abstract] [Full Text] [Related]
6. Cause-specific mortality after diagnosis of thyroid cancer: a large population-based study.
Du B; Wang F; Wu L; Wang Z; Zhang D; Huang Z; Gao L; Li Y; Liang C; Li P; Yao R
Endocrine; 2021 Apr; 72(1):179-189. PubMed ID: 32770440
[TBL] [Abstract][Full Text] [Related]
7. Racial Differences in 20-Year Cardiovascular Mortality Risk Among Childhood and Young Adult Cancer Survivors.
Berkman AM; Brewster AM; Jones LW; Yu J; Lee JJ; Peng SA; Crocker A; Ater JL; Gilchrist SC
J Adolesc Young Adult Oncol; 2017 Sep; 6(3):414-421. PubMed ID: 28530506
[TBL] [Abstract][Full Text] [Related]
8. Risk and prognostic factors of breast cancer with liver metastases.
Ji L; Cheng L; Zhu X; Gao Y; Fan L; Wang Z
BMC Cancer; 2021 Mar; 21(1):238. PubMed ID: 33676449
[TBL] [Abstract][Full Text] [Related]
9. Different patterns in the prognostic value of age for breast cancer-specific mortality depending on hormone receptor status: a SEER population-based analysis.
Liu YR; Jiang YZ; Yu KD; Shao ZM
Ann Surg Oncol; 2015 Apr; 22(4):1102-10. PubMed ID: 25249260
[TBL] [Abstract][Full Text] [Related]
10. A population-based study of cardiovascular disease mortality risk in US cancer patients.
Sturgeon KM; Deng L; Bluethmann SM; Zhou S; Trifiletti DM; Jiang C; Kelly SP; Zaorsky NG
Eur Heart J; 2019 Dec; 40(48):3889-3897. PubMed ID: 31761945
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of patients with inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes: A population-based study from the SEER program.
Li J; Xia Y; Wu Q; Zhu S; Chen C; Yang W; Wei W; Sun S
Oncotarget; 2017 Jul; 8(30):49370-49379. PubMed ID: 28472761
[TBL] [Abstract][Full Text] [Related]
12. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.
Ma H; Lu Y; Malone KE; Marchbanks PA; Deapen DM; Spirtas R; Burkman RT; Strom BL; McDonald JA; Folger SG; Simon MS; Sullivan-Halley J; Press MF; Bernstein L
BMC Cancer; 2013 May; 13():225. PubMed ID: 23642215
[TBL] [Abstract][Full Text] [Related]
13. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
Narod SA; Iqbal J; Giannakeas V; Sopik V; Sun P
JAMA Oncol; 2015 Oct; 1(7):888-96. PubMed ID: 26291673
[TBL] [Abstract][Full Text] [Related]
14. High cardiovascular disease mortality after endometrial cancer diagnosis: Results from the Surveillance, Epidemiology, and End Results (SEER) Database.
Felix AS; Bower JK; Pfeiffer RM; Raman SV; Cohn DE; Sherman ME
Int J Cancer; 2017 Feb; 140(3):555-564. PubMed ID: 27741565
[TBL] [Abstract][Full Text] [Related]
15. Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.
Schroeder MC; Rastogi P; Geyer CE; Miller LD; Thomas A
Oncologist; 2018 Apr; 23(4):481-488. PubMed ID: 29330212
[TBL] [Abstract][Full Text] [Related]
16. Older Patients With Early-stage Breast Cancer: Adjuvant Radiation Therapy and Predictive Factors for Cancer-related Death.
Nagar H; Yan W; Christos P; Chao KSC; Nori D; Ravi A
Am J Clin Oncol; 2017 Jun; 40(3):300-305. PubMed ID: 25333731
[TBL] [Abstract][Full Text] [Related]
17. Racial disparities in breast cancer survival: an analysis by age and stage.
Deshpande AD; Jeffe DB; Gnerlich J; Iqbal AZ; Thummalakunta A; Margenthaler JA
J Surg Res; 2009 May; 153(1):105-13. PubMed ID: 19084242
[TBL] [Abstract][Full Text] [Related]
18. The prognosis analysis of different metastasis pattern in patients with different breast cancer subtypes: a SEER based study.
Wang H; Zhang C; Zhang J; Kong L; Zhu H; Yu J
Oncotarget; 2017 Apr; 8(16):26368-26379. PubMed ID: 28038448
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of young age (<35 years) by subtype based on ER, PR, and HER2 status in breast cancer: a nationwide registry-based study.
Kim EK; Noh WC; Han W; Noh DY
World J Surg; 2011 Jun; 35(6):1244-53. PubMed ID: 21472372
[TBL] [Abstract][Full Text] [Related]
20. Increased risk of breast cancer-specific mortality among cancer survivors who developed breast cancer as a second malignancy.
Wang C; Hu K; Deng L; He W; Fang F; Tamimi RM; Lu D
BMC Cancer; 2021 May; 21(1):491. PubMed ID: 33941118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
